Company Performance Metrics
R. Scott Struthers: Founder & Chief Executive Officer
Yun-Fei Zhu: Co-Founder & Vice President, Chemistry
Crinetics Pharmaceuticals discovers, develops, and commercializes medicines for endocrine diseases and endocrine-related tumors. The company focuses on therapies that target hormone-related conditions by applying research in endocrinology and G protein-coupled receptor biology to identify and advance drug candidates. Its pipeline includes
treatments for rare endocrine disorders and other diseases influenced by hormone signaling, spanning research, clinical development, regulatory activities, and commercialization. Crinetics also conducts scientific research to expand therapeutic options for endocrine conditions and collaborates with healthcare professionals, researchers, and patient communities to support the development and delivery of new medicines.
